| Authors: |
Gamper EM; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Psychiatry II, Medial University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: eva-maria.gamper@i-med.ac.at., King MT; School of Psychology, University of Sydney, Camperdown, NSW, Australia., Shaw JW; Global Health Economics and Outcomes Research, Bristol Myers Squibb, Lawrenceville, NJ, USA., Schiel A; Department of Health Economy, Norwegian Medicines Agency, Oslo, Norway., Kalo Z; Center for Health Technology Assessment and Center for Pharmacology and Drug Research and Development, Semmelweis University, Budapest, Hungary; Syreon Research Institute, Budapest, Hungary., van der Weijst L; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Cella D; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Reijneveld JC; Department of Neurology and Brain Tumor Center, Amsterdam University Medical Center, Amsterdam, Netherlands; Department of Neurology, Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands., Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. |
